Box score
Capstan Therapeutics, Inc.
Reported $87.5M sold in a new Form D filed March 20, 2024 (San Diego, California).
- Biggest raise
- $87.5M filed Mar 20, 2024
- League
- Bio & Health Biotechnology
- Based in
- San Diego, California
- Season rank
- #58 of 1,389 in the Bio & Health League; #226 of 12,443 overall (2024)
- Incorporated
- 2020
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-03-20 | New notice | $87.5M | $175M | SEC |
| 2024-03-20 | New notice not ranked | $76.5M | $102M | SEC |
| 2024-03-20 | New notice not ranked | $63M | $63M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2015437.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | TRC 2004, Inc. rookie | Bio & Health | $90M |
| 2 | BlossomHill Therapeutics, Inc. | Bio & Health | $88.6M |
| 3 | Aardvark Therapeutics, Inc. | Bio & Health | $85M |
| 4 | Enlaza Therapeutics, Inc. | Bio & Health | $84M |
| 5 | Willow Innovations, Inc. | Bio & Health | $81.4M |
| 6 | Cortica Inc. | Bio & Health | $81M |